The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate deficiency, a rare disorder.

FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same ...

Thyroid disorders, polycystic ovary syndrome (PCOS), autoimmune diseases, osteoporosis, and iron deficiency anaemia are some of the health conditions that affect women more than men.

Adults with a deficiency of vitamin D are at increased risk for developing dry eye disease than those without low levels of the nutrient, a study finds.

The FDA has approved Wellcovorin (leucovorin) for cerebral folate deficiency (CFD-FOLR1), the first-ever treatment for the rare genetic neurological condition.

The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

It's a major step back from statements made at a White House news conference in September, when President Donald Trump and ...

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...

Washington — The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children with the much ...

The FDA has expanded its approval of leucovorin calcium tablets to treat cerebral folate deficiency in patients with a folate receptor 1 gene variant, according to a press release from the agency.